enVVeno Medical Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.2% | -40.9% | -78.5% | -28.1% | +528.1% | -82.3% | +168.4% | -50.0% | -26.9% | +2.6% | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -46.6% | -11.0% | – | – | -20.9% | -74.7% | +0.0% | +0.5% | +2,732.8% | – | – | +7.9% | +1.0% | -18.0% | +20.1% | -4.7% | -2.6% | +8.0% | +3.7% | +11.8% | +1.2% | +6.1% | +3.1% | +0.0% | -2.3% | +4.6% | +1.5% | +0.0% | -2.9% | +5.2% | -3.5% | -5.1% | -5.4% | +0.0% | +6.6% | -7.7% | -2.5% | +6.0% | – | – | |
| – | – | -116.2% | – | -455.9% | – | -104.9% | – | -83.5% | +267.7% | +2.6% | -408.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +154.5% | -76.7% | +710.5% | -31.1% | +16.6% | +51.4% | -30.9% | +6.7% | +36.8% | +58.1% | +16.4% | -35.2% | +38.3% | +7.4% | +200.4% | -28.3% | -33.2% | +12.4% | +45.5% | -12.9% | +98.0% | -18.9% | +12.2% | +28.5% | +17.2% | -33.6% | +6.5% | +2.4% | -7.4% | +1.2% | +22.9% | -27.2% | +13.1% | -10.6% | -24.6% | +8.4% | -1.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +61.6% | -37.5% | +10.1% | +14.4% | +386.6% | -47.5% | +3.4% | -6.5% | +0.1% | -12.6% | -18.8% | -1.9% | +29.2% | -25.7% | +7.3% | +25.9% | -3.8% | -24.8% | +73.5% | -44.7% | -10.1% | -5.5% | -11.8% | – | |
| – | +28.1% | -8.6% | +13.2% | +31.8% | +17.8% | -26.3% | +117.4% | -52.7% | -40.9% | +82.6% | +15.5% | -7.2% | -7.2% | -11.4% | +1.4% | +26.4% | +122.8% | -33.4% | -15.8% | +13.5% | +243.0% | -41.3% | +31.6% | -12.2% | +5.2% | +5.2% | +0.2% | -21.9% | +17.9% | -12.7% | -0.8% | +13.6% | +8.9% | -26.5% | +43.2% | -31.2% | -18.2% | +4.3% | -6.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -48.4% | +24.7% | +324.9% | +1,036.3% | +218.8% | +235.6% | -55.7% | -99.1% | -11.3% | -97.3% | +0.2% | +3,998.3% | +160.8% | -94.7% | -91.3% | +147.4% | +96.1% | – | – | -32.5% | +313.7% | -73.3% | +640.0% | +45.9% | -22.2% | +864.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -48.4% | +24.7% | +69.5% | +2,748.8% | -75.6% | +93.1% | -46.8% | – | – | – | +61.6% | +37.4% | +3,019.6% | -100.4% | – | -35.2% | -100.6% | – | – | – | – | -153.5% | – | -171.1% | – | – | – | – | – | -93.3% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -4,490.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.